Inhaled flow and handling of Fluticasone Diskhaler by asthmatic patients

Tokai Journal of Experimental and Clinical Medicine

Volumn 25, Issue 2, 2000, Pages 79-85

  Kondo, Tetsuri ^a   Wakita, Kaoru ^b   Hayashi, Yoshihiro ^b   Shoyama, Yutaka ^b   Ono, Yoshiaki ^b   Ohta, Yasuyo ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Bronchial asthma; Dry powder; Flow of inhalation; Inhaled steroid

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE;

ARTICLE; ASTHMA; BREATH HOLDING; DRUG DELIVERY SYSTEM; DRY POWDER; ERROR; FLOW RATE; HUMAN; MAJOR CLINICAL STUDY; METERED DOSE INHALER; PATIENT SATISFACTION; POWDER INHALER;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; POWDERS;

EID: 0033776825     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Johnson M: Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 101: S434-439, 1998.
2. Kesten S, Elias M, Cartier A, Chapman KR: Patient handling of a multidose clry power inhalation device for albuterol. Chest 105: 1077-1081, 1994.
3. Shieh W: Preference for the Diskhaler rather than the metered dose inhaler in patients with airway obstruction. Chang Gung Med J 17: 20-27, 1994.
4. Palen J, Klein JJ, Kerkhoff AHM, et al.: Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. Thorax 50: 1183-1187, 1995.
5. Sumby BS, Cooper SM, Smith IJ: A comparison of the inspiratory effort required to operate the Diskhaler inhaler and Turbohaler inhaler in the administration of powder drug formulation. Brit J Clin Res 3: 117-123, 1992.
6. Kondo T, Tazaki G, Hirokawa Y, et al.: Peak inspiratory flow during a Diskhaler use in subjects unfamiliar with dry powder devices. Jpn J Allergol 48: 621-625, 1999.
7. Barnes PJ: Inhaled glucocorticoids for asthma. New Engl J Med 332: 868-875, 1995.
8. Jatulis DE, Meng Y, Elashoff RM, et al.: Preventive pharmacologic therapy among asthmatics: five years after publication of guidelines. Ann Allergy Asthma Immunol 81: 82-88, 1998.
9. Apter AJ, Reisine ST, Affleck G, et al.: Adherence with twice-daily dosing of inhaled steroids. Am J Respir Crit Care Med 157: 1810-1817, 1998.
10. Vaswani SK, Creticos PS: Metered dose inhaler: past, present, and future. Ann Allergy Asthma Immunol 80: 11-21, 1998.
11. Barnes PJ, O'Connor BJ: Use of a fixed combination beta2 -agonist and steroid dry powder inhaler in asthma. Am J Respir Crit Care Med 151: 1053-57, 1995.
12. Malton A, Sumby BS, Dandiker Y: A comparison of in-vitro drug delivery from salbutamol Diskus and terbutaline Turbohaler. J Pharm Med 6: 35-48, 1996.
13. Steckel H, Muller BW: In vitro evaluation of dry powder inhalers I: drug deposition of commonly used devices. Internat J Pharmaceut 154: 19-29, 1997.
14. Nielsen KG, Auk IL, Bojsen K, et al.: Clinical effect of Disk us dry-powder at low and high inspiratory flow-rates in asthmatic children. Eur Respir J 11: 350 -354, 1998.
15. Ganderton D: General factors influencing drug delivery to the lung. Respir Med 91: 13-16, 1997.